Abstract
Hepatitis C virus (HCV) is associated with various types of tumors. Our study examines the prevalence of hepatitis C infection in myeloma and compares the findings with a control group. Our results show a prevalence of HCV of 32% in the myeloma patients compared with a prevalence of 9% in the control group, with an odds ratio of 4.3, Cl 95% 1.8-11.0 (p=0.001).
Original language | English |
---|---|
Pages (from-to) | 883-884 |
Number of pages | 2 |
Journal | Haematologica |
Volume | 85 |
Issue number | 8 |
Publication status | Published - 2000 |
Keywords
- Hepatitis C virus
- Immune system
- Multiple myeloma
ASJC Scopus subject areas
- Hematology